Marpai (MRAI) Competitors $1.33 +0.03 (+2.40%) As of 01:14 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. KDLY, QIPT, PIII, BDSX, OPGN, CCM, BNR, ENZ, BRTX, and MGRXShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Kindly MD (KDLY), Quipt Home Medical (QIPT), P3 Health Partners (PIII), Biodesix (BDSX), OpGen (OPGN), Concord Medical Services (CCM), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry. Marpai vs. Kindly MD Quipt Home Medical P3 Health Partners Biodesix OpGen Concord Medical Services Burning Rock Biotech Enzo Biochem BioRestorative Therapies Mangoceuticals Kindly MD (NASDAQ:KDLY) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends, community ranking and institutional ownership. Which has stronger earnings & valuation, KDLY or MRAI? Kindly MD has higher earnings, but lower revenue than Marpai. Kindly MD is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindly MD$2.47M62.33-$4.64M-$0.77-33.21Marpai$34.87M0.57-$28.75M-$1.82-0.73 Is KDLY or MRAI more profitable? Kindly MD has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Kindly MDN/A N/A N/A Marpai -85.70%N/A -100.23% Does the media refer more to KDLY or MRAI? In the previous week, Kindly MD had 5 more articles in the media than Marpai. MarketBeat recorded 7 mentions for Kindly MD and 2 mentions for Marpai. Kindly MD's average media sentiment score of 0.65 beat Marpai's score of 0.57 indicating that Kindly MD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kindly MD 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marpai 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in KDLY or MRAI? 49.8% of Marpai shares are owned by institutional investors. 50.5% of Kindly MD shares are owned by insiders. Comparatively, 61.3% of Marpai shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer KDLY or MRAI? Marpai received 2 more outperform votes than Kindly MD when rated by MarketBeat users. CompanyUnderperformOutperformKindly MDN/AN/AMarpaiOutperform Votes266.67% Underperform Votes133.33% SummaryKindly MD beats Marpai on 7 of the 12 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$19.83M$2.03B$24.41B$8.44BDividend YieldN/A6.99%2.48%4.11%P/E Ratio-0.5015.9233.5019.78Price / Sales0.573.51266.79118.91Price / CashN/A9.3230.9334.62Price / Book-0.773.935.434.52Net Income-$28.75M$87.49M$196.34M$248.23M7 Day Performance10.02%-4.23%-0.28%0.81%1 Month Performance38.67%-4.69%16.17%13.32%1 Year Performance-33.44%-28.78%18.24%7.69% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.33+2.4%N/A-34.0%$19.83M$34.87M-0.50150High Trading VolumeKDLYKindly MD1.1041 of 5 stars$11.80-13.8%N/AN/A$71.06M$2.72M-15.32N/ANews CoverageGap UpHigh Trading VolumeQIPTQuipt Home Medical1.6873 of 5 stars$1.62-23.9%$6.25+285.8%-38.7%$69.81M$244.72M-9.53800News CoverageAnalyst DowngradeHigh Trading VolumePIIIP3 Health Partners2.2091 of 5 stars$8.29-1.9%$16.25+96.0%-70.6%$59.54M$1.50B-9.87500Earnings ReportBDSXBiodesix3.294 of 5 stars$0.36-1.2%$2.83+697.9%-74.8%$52.00M$71.32M-0.91220Analyst ForecastGap DownHigh Trading VolumeOPGNOpGenN/A$4.85-2.4%N/A+41.0%$40.53M$2.67M0.00100News CoverageAnalyst ForecastCCMConcord Medical Services0.6537 of 5 stars$8.65+5.5%N/A+20.1%$37.56M$383.96M0.00970Analyst ForecastBNRBurning Rock Biotech0.4497 of 5 stars$2.45-0.4%N/A-59.2%$25.10M$515.82M-0.821,390Upcoming EarningsGap DownENZEnzo BiochemN/A$0.33-14.8%N/A-69.0%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.3258 of 5 stars$1.69-8.6%$18.00+967.2%+23.0%$12.66M$401,000.00-1.107Analyst RevisionMGRXMangoceuticals0.189 of 5 stars$1.65-4.1%N/A-98.7%$8.53M$615,873.00-0.293Earnings Report Related Companies and Tools Related Companies Kindly MD Competitors Quipt Home Medical Competitors P3 Health Partners Competitors Biodesix Competitors OpGen Competitors Concord Medical Services Competitors Burning Rock Biotech Competitors Enzo Biochem Competitors BioRestorative Therapies Competitors Mangoceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRAI Stock Free MRAI Stock Alerts